The purpose of this randomized, control pilot study is to measure the effects of a gentle, 12 week hatha yoga program on post-menopausal, obese, sedentary South Asian women at risk for cardiovascular disease. Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques. The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
50
12 week 90 minute hatha yoga session offered three (3x) per week. Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques. The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.
The Jim Pattison Outpatient Care and Surgery Services, Cardiovascular Outpatient Clinic
Surrey, British Columbia, Canada
RECRUITINGKwantlen Polytechnic University
Surrey, British Columbia, Canada
NOT_YET_RECRUITINGChange in blood pressure
blood pressure is measured as a specific physiologic index of cardiovascular risk.
Time frame: baseline, at end of study (12 wks), & 3 months post-study
Change in subjective well-being
The Perceived Stress Scale and Abbreviated Duke Social Support Index will be used to measure subjective well-being.
Time frame: baseline, at end of study (12 wks), & 3 months post-study
Change in perceived physical well-being
Pittsburgh Sleep Quality Index, Physical Activity Scale for the Elderly, and Exercise Regularly Scale will be used to measure change in perceived physical well-being
Time frame: baseline, end of study (12 wks) & 3 months post-study
Change in insulin sensitivity
Fasting insulin \& glucose will be measured for change in insulin sensitivity as a related index of cardiovascular risk
Time frame: baseline, end of study (12 wks) & 3 months post-study
Change in inflammation
C-reactive protein will be measured for change in inflammation as a related index of cardiovascular risk
Time frame: baseline, end of study (12 wks) & 3 months post-study
Change in serum total cholesterol
Serum total cholesterol will be measured as a related index of cardiovascular risk
Time frame: baseline, end of study (12 wks) & 3 months post-study
Change in serum high-density lipoprotein (HDL) cholesterol
Serum high-density lipoprotein (HDL) cholesterol will be measured as a related index of cardiovascular risk
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: baseline, end of study (12 wks) & 3 months post-study
Change in serum low-density lipoprotein (LDL) cholesterol
Serum low-density lipoprotein (LDL)cholesterol will be measured as a related index of cardiovascular risk
Time frame: baseline, end of study (12 wks) & 3 months post-study
Change in serum triglycerides
Serum triglycerides will be measured as a related index of cardiovascular risk
Time frame: baseline, end of study (12 wks) & 3 months post-study
Change in waist circumference.
Waist circumference will be measured for change in visceral adiposity as a related index of cardiovascular risk
Time frame: baseline, end of study (12 wks) & 3 months post-study
Change waist-hip ratio
Waist-hip ratio will be measured for change in visceral adiposity as a related index of cardiovascular risk
Time frame: baseline, end of study (12 wks) & 3 months post-study
Change in body mass index (BMI)
Body mass index (BMI) will be measured for change in visceral adiposity as a related index of cardiovascular risk
Time frame: baseline, end of study (12 wks) & 3 months post-study
Change in resting heart rate
Resting heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk
Time frame: baseline, end of study (12 wks) & 3 months post-study
Change in heart rate
Heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk
Time frame: baseline, at end of study (12 wks), & 3 months post-study